Questions: Metabolomics

Question 1

Why is metabolomics considered the closest 'omics layer to the phenotype?

• A. Because metabolites are the largest molecules in the cell
• B. Because metabolites are the functional endpoints of gene expression, enzyme activity, and environmental inputs
• C. Because metabolomics uses the most expensive instruments
• D. Because metabolite levels do not change over time

Answer: (B)

Metabolites are the end products and intermediates of cellular biochemistry. A change in gene expression must propagate through transcription, translation, and enzyme activity before it affects metabolite levels — but metabolite levels also respond directly to diet, drugs, microbiome activity, and environmental conditions. This makes metabolomics uniquely sensitive to the organism's actual physiological state, not just its genetic potential. A diabetic patient's elevated blood glucose is a metabolite phenotype that genomics alone cannot detect.

Question 2

Untargeted metabolomics can identify and quantify every metabolite present in a biological sample.

• T. True
• F. False

Answer: False

Current platforms detect hundreds to a few thousand metabolites from a sample that likely contains tens of thousands. Detection depends on the metabolite's abundance, ionization efficiency (for MS), chemical properties, and whether it falls within the analytical range of the platform. Furthermore, many detected features (mass-to-charge peaks) cannot be confidently identified because they do not match entries in metabolite databases. Metabolite identification remains the primary bottleneck in untargeted metabolomics, requiring spectral libraries, authentic standards, and often manual curation.

Question 3

Explain the complementary roles of targeted and untargeted metabolomics in a research study.

Model answer: Untargeted metabolomics is exploratory — it scans broadly to discover unexpected metabolic changes without prior hypotheses, identifying features that differ between conditions even if they were not anticipated. However, its quantification is semi-quantitative at best, and many features may be unidentified. Targeted metabolomics is confirmatory — it measures a predefined panel of metabolites with high accuracy and precision using calibration curves and internal standards. A typical study design uses untargeted analysis first to generate hypotheses about altered pathways, then uses targeted analysis to precisely quantify key metabolites and validate the findings.

This discovery-then-validation workflow mirrors the broader logic of omics research: cast a wide net first (genome-wide, untargeted) to find signals, then focus precisely (candidate gene, targeted assay) to confirm them. The two approaches have fundamentally different strengths: breadth versus accuracy.